Author Correction: Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Scribble mis-localization drives adaptive resistance to KRAS G12C inhibitors via YAP-induced MRAS and feedback activation of MAPK signaling

  • By

  • Yuta Adachi

  • Ryo Kimura

  • Kentaro Hirade

  • Shogo Yanase

  • Yuki Nishioka

  • Natsumi Kasuga

  • Rui Yamaguchi

  • Hiromichi Ebi

  • October 19, 2026

Share

  • 1

    A correction to the Nature Cancer article was published online on June 5, 2023.

  • 2

    A clerical error affected the Source Data for Extended Data Figure 1f and its accompanying plot.

  • 3

    Three NCI-H358 snail control values were duplicated and substituted for the NCI-H358 ZEB1 control values.

  • 4

    The error resulted in incorrect values in both the Source Data and the Extended Data Figure 1f panel.

  • 5

    The corrected figure and Source Data are available in the article’s HTML and PDF versions, and the original figure accompanies the amendment as Supplementary Information.

Original Source(s)

Author Correction: Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS

  • by Yuta Adachi, Ryo Kimura, Kentaro Hirade, Shogo Yanase, Yuki Nishioka, Natsumi Kasuga, Rui Yamaguchi, Hiromichi Ebi

  • October 19, 2026

Related Content

2026 ASCO Breast Cancer Highlights: SENOMAC

Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss highlights from the SENOMAC trial which sheds light on whether some patients with early breast cancer and limited lymph node involvement can safely avoid additional axillary surgery.

  • October 15, 2026

  • 1 min
Construction of an AI-Assisted Pedigree Mapping System for Hereditary Gynecological Tumors: Algorithm Development and Pilot Validation Study

Association of Adjuvant Radiotherapy De-Escalation With Outcomes Following Oncoplastic Breast-Conserving Surgery